About the Centre

The Centre for Translational Neuroscience (CTN) aims to:

1. Study the mechanism of the development of obesity and search for
   better strategies to prevent and treat obesity and its metabolic related
   disorders.
2. Investigate the neuropathology of schizophrenia.
3. Study the interruption to brain development at an early stage which
   can alter chemically coded neural networks affecting behaviour in later life.

 Our expertise lies in modern molecular neurobiological technology, animal behavioural test, and neuropharmacology.

The CTN has been a participant in the Neuroscience Institute of Schizophrenia and Allied Disorders (NISAD), via the NISAD- Wollongong Centre for Brain Research, since 1999. The CTN ’s work through NISAD focuses on the brain pathology of schizophrenia, while National Health and Medical Research Council (NHMRC) and AstraZeneca Pharmaceutical Company based research focuses on chemical coded neural network in body weight control. Using beta-imager, molecular neurobiological, immunohistochemical and behavioural testing techniques, the CTN examines the brain pathology of cyto- and chemo-architecture in schizophrenia and neural networks controlling body weight.